← Back to Search

Physical activity coaching for Cardiovascular Health (MHC3 Trial)

N/A
Waitlist Available
Led By Euan A Ashley, MRCP, DPhil
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured monthly during the 12 week duration of the study
Awards & highlights

MHC3 Trial Summary

This trial uses mobile devices to study how daily activity affects cardiovascular health, in the hopes of informing future health guidelines.

MHC3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured monthly during the 12 week duration of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured monthly during the 12 week duration of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in daily step count
Secondary outcome measures
Change in daily self-reported happiness
Change in recovery heart rate
Change in resting heart rate
+1 more

MHC3 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physical activity coachingExperimental Treatment1 Intervention
In addition to the tasks performed and feedback received by the Control arm (see above), the intervention arm will also undergo daily coaching with the goal of increasing their daily step count. Members of this arm will receive daily app notifications indicating that they have activities to complete. They will be provided with 5 exercise options: Low intensity activity options (i.e. walking in the part, bicycling to the store, etc.). Moderate to vigorous endurance activity, performed on their own (running, bicycling, rowing, swimming, etc) An on demand "group session" video No exercise today Alternate physical activity -- the participants will have the option to record alternate physical activity that they performed Participants will be asked to indicate if they completed the exercise with three options: Yes No Request for a different exercise to be shown
Group II: ControlActive Control1 Intervention
At the end of this initial week of monitoring, participants will be randomized to a control group or an intervention group. Both groups will be followed for three months, with outcome measurements collected monthly. Both arms will continue to receive their seven day physical activity assessment using the phone's core motion sensors and HealthKit/ Google Health step count. Both groups will also be prompted to complete monthly fitness tests: the 6-minute walk test, a 12 minute run test, and the Tecumseh step test.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical activity coaching
2014
N/A
~80

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,394 Previous Clinical Trials
17,341,610 Total Patients Enrolled
1 Trials studying Cardiovascular Health
2,000,000 Patients Enrolled for Cardiovascular Health
Google LLC.Industry Sponsor
11 Previous Clinical Trials
31,671 Total Patients Enrolled
Anna Shcherbina, MEngStudy DirectorStanford University

Frequently Asked Questions

~0 spots leftby Apr 2025